Menveo 1 vial-a-c-y-w-135-DIP 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJH8J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,282
Award facts
- Contract value 100% obligated
- $50,282.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $50,282.40 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 14, 2026, for Menveo 1 vial (meningococcal vaccine covering serogroups A, C, Y, and W-135) with completion scheduled for January 15, 2026. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of parent company Cencora, Inc. (formerly AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order represents a task order execution under Cencora, Inc.'s significant Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2031. The IDC serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, vaccines, generic and brand-name drugs, and critical medical commodities. The vaccine delivery supports the Defense Health Agency and military treatment facilities' immunization requirements, reflecting the contractor's established role as a strategic pharmaceutical prime vendor for DoD medical supply operations.
Quick answers
Who was awarded contract SPE2DR26FJH8J?
SPE2DR26FJH8J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FJH8J worth?
The government has obligated $50,282 on SPE2DR26FJH8J.
Is contract SPE2DR26FJH8J an order under another contract?
Yes. SPE2DR26FJH8J is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH8J competed?
The extent of competition for SPE2DR26FJH8J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award